Research Article

Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents

Figure 4

Representative coronal SPECT/CT images of W256 tumor-bearing rats 3 h following injection of 131I-H33258. Tumors were treated with vehicle or CA4P 24 h prior to injection of 131I-H33258 and obvious tracer uptake was observed in CA4P treated tumor on right hind flank. Tumors are denoted by red arrows.